10 February 2023 | News
The office is expected to help accelerate the adoption of the company's innovative digital technologies for clinical research across the region
Image credit: prnewswire
China-based Taimei Technology, a digital cooperation platform for the life science industry, has announced the opening of its new office in Singapore. The office, strategically located in one of the world's financial centres as well as one of Asia Pacific or APAC's economic and cultural centres, is expected to help accelerate the adoption of the company's innovative digital technologies for clinical research across the region and provide local customers with better services and experience with the support of local resources, while working with Taimei's partners to improve the application of digital technologies in regional clinical research and empower pharmaceutical innovations.
Taimei Technology chairman and CEO Lu Zhao said, "With our Drug R&D Digital Cooperation Platform TrialOS, we have built a complete digital product system for clinical research and pharmacovigilance. Looking ahead, Taimei Technology plans to focus on its growth by increasing its investments in the APAC market through the new Singapore office, and facilitate the implementation of additional collaborative projects."
Taimei Technology vice president, general manager of clinical research BU and APAC head Nate Zhang added, "With the TrialOS platform, we expect to further our collaboration with local customers and partners with the aim of accelerating the adoption of advanced digital technologies used in clinical research, improving the efficiency of clinical research operations, and speeding up the R&D of new drugs to benefit more patients by providing them with easier access to effective and affordable drugs."